REFERENCES
1. Winans B, Humble MC, Lawrence BP. Environmental toxicants and the
developing immune system: a missing link in the global battle against
infectious disease? Reprod Toxicol. 2011;31(3):327-336.
2. Yang SI. Particulate matter and childhood allergic diseases.Korean J Pediatr. 2019;62(1):22-29.
3. Brock JW, Caudill SP, Silva MJ, Needham LL, Hilborn ED. Phthalate
monoesters levels in the urine of young children. Bull Environ
Contam Toxicol. 2002;68(3):309-314.
4. Jaakkola JJ, Knight TL. The role of exposure to phthalates from
polyvinyl chloride products in the development of asthma and allergies:
a systematic review and meta-analysis. Environ Health Perspect.2008;116(7):845-853.
5. Just AC, Whyatt RM, Miller RL, et al. Children’s urinary phthalate
metabolites and fractional exhaled nitric oxide in an urban cohort.Am J Respir Crit Care Med. 2012;186(9):830-837.
6. Cakmak S, Dales RE, Hebbern C, Saravanabhavan G. The association
between urinary phthalates and lung function. J Occup Environ
Med. 2014;56(4):376-381.
7. Kim MA, Yon DK, Jee HM, et al. Association of phthalates with nasal
patency and small airway dysfunction in first-grade elementary school
children. Allergy. 2020.
8. Jahreis S, Trump S, Bauer M, et al. Maternal phthalate exposure
promotes allergic airway inflammation over 2 generations through
epigenetic modifications. J Allergy Clin Immunol.2018;141(2):741-753.
9. Oie L, Hersoug LG, Madsen JO. Residential exposure to plasticizers
and its possible role in the pathogenesis of asthma. Environ
Health Perspect. 1997;105(9):972-978.
10. Masuoka M, Shiraishi H, Ohta S, et al. Periostin promotes chronic
allergic inflammation in response to Th2 cytokines. J Clin
Invest. 2012;122(7):2590-2600.
11. Tong X, Wang D, Liu S, et al. The YKL-40 protein is a potential
biomarker for COPD: a meta-analysis and systematic review. Int J
Chron Obstruct Pulmon Dis. 2018;13:409-418.
12. Lee S, Koh HY, Yon DK, et al. Association of Sensitization to
Different Aeroallergens With Airway Function and Nasal Patency in Urban
Children. Allergy Asthma Immunol Res. 2019;11(4):572-582.
13. Lee SI, Shin MH, Lee HB, et al. Prevalences of symptoms of asthma
and other allergic diseases in korean children: a nationwide
questionnaire survey. J Korean Med Sci. 2001;16(2):155-164.
14. Koch HM, Lorber M, Christensen KL, Palmke C, Koslitz S, Bruning T.
Identifying sources of phthalate exposure with human biomonitoring:
results of a 48h fasting study with urine collection and personal
activity patterns. Int J Hyg Environ Health. 2013;216(6):672-681.
15. Gascon M, Casas M, Morales E, et al. Prenatal exposure to bisphenol
A and phthalates and childhood respiratory tract infections and allergy.J Allergy Clin Immunol. 2015;135(2):370-378.
16. Beydon N, Davis SD, Lombardi E, et al. An official American Thoracic
Society/European Respiratory Society statement: pulmonary function
testing in preschool children. Am J Respir Crit Care Med.2007;175(12):1304-1345.
17. Boccaccino A, Peroni DG, Pietrobelli A, et al. Assessment of
variable obstruction by forced expiratory volume in 1 second, forced
oscillometry, and interrupter technique. Allergy Asthma Proc.2007;28(3):331-335.
18. Dweik RA, Boggs PB, Erzurum SC, et al. An official ATS clinical
practice guideline: interpretation of exhaled nitric oxide levels (FENO)
for clinical applications. Am J Respir Crit Care Med.2011;184(5):602-615.
19. Tingley D, Yamamoto T, Hirose K, Keele L, Imai K. mediation: R
Package for Causal Mediation Analysis. J Stat Softw. 2014;59(5).
20. Shea KM, American Academy of Pediatrics Committee on Environmental
H. Pediatric exposure and potential toxicity of phthalate plasticizers.Pediatrics. 2003;111(6 Pt 1):1467-1474.
21. Kueseng P, Thavarungkul P, Kanatharana P. Trace phthalate and
adipate esters contaminated in packaged food. J Environ Sci Health
B. 2007;42(5):569-576.
22. In: Phthalates and Cumulative Risk Assessment: The Tasks
Ahead. Washington (DC)2008.
23. Woodruff PG, Modrek B, Choy DF, et al. T-helper type 2-driven
inflammation defines major subphenotypes of asthma. Am J Respir
Crit Care Med. 2009;180(5):388-395.
24. Chupp GL, Lee CG, Jarjour N, et al. A chitinase-like protein in the
lung and circulation of patients with severe asthma. N Engl J
Med. 2007;357(20):2016-2027.
25. Konradsen JR, James A, Nordlund B, et al. The chitinase-like protein
YKL-40: a possible biomarker of inflammation and airway remodeling in
severe pediatric asthma. J Allergy Clin Immunol.2013;132(2):328-335 e325.
26. Tang H, Fang Z, Sun Y, et al. YKL-40 in asthmatic patients, and its
correlations with exacerbation, eosinophils and immunoglobulin E.Eur Respir J. 2010;35(4):757-760.
27. Shirai T, Hirai K, Gon Y, et al. Combined Assessment of Serum
Periostin and YKL-40 May Identify Asthma-COPD Overlap. J Allergy
Clin Immunol Pract. 2019;7(1):134-145 e131.
28. Corren J, Lemanske RF, Hanania NA, et al. Lebrikizumab treatment in
adults with asthma. N Engl J Med. 2011;365(12):1088-1098.